Top Biotech Penny Stocks to Watch — April 28, 2021

After a few quiet weeks, biotech penny stocks are back in full force. 

And it’s not just penny stocks…

Higher-priced biotech stocks had huge runs recently — like Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Ocugen, Inc. (NASDAQ: OCGN), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), and Vaxart, Inc. (NASDAQ: VXRT).

(OCGN was on my watchlist on Thursday. Check it out on my blog every Tuesday, Thursday, and Friday if you like trading higher-priced stocks. And not that past performance is not indicative of future results.)

These big runners could bring momentum and sympathy plays to the entire sector. So be prepared to take advantage of any opportunities.

Many of this week’s stocks to watch are moving on recent news. Plus, I’m watching two psychedelic drug companies. I traded one on Monday, and Challenge trader Matthew Monaco caught the action, too. (More on that in a bit.)

Find out how I did on my trade and more. Here’s the top biotech penny stocks list … I’ll show you what’s on my radar and why.

Top Biotech Penny Stocks to Watch

These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.

Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…

How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.

And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7

Or try it with the Breaking News Chat for only $17!

(*Please note: My results are far from typical. Individual results will vary. Most traders lose money. I have the benefit of years of hard work, dedication, and experience. Trading is inherently risky. Do your due diligence and never risk more than you can afford to lose.)

Now, let’s get to the top biotech penny stocks to watch this week…

Biotech Penny Stocks #1: Galectin Therapeutics Inc. (NASDAQ: GALT)

GALT was on the watchlist last week after it announced a world-renowned neurosurgeon joined the company as a consultant to develop its treatment for liver diseases and cancer.

Since then, the stock had a multi-day breakout over $3.27 and a multi-month breakout over $3.85. (Past performance is not indicative of future results.) 

On April 19, the company filed a Form 4 showing a director acquired two million shares in convertible notes.

Yesterday the company announced its “Chief Medical Officer, will present the belapectin program at the 4th Global NASH Congress taking place virtually on April 28 and 29, 2021.” Read the full press release here.

The stock’s up a lot. I won’t chase. I’ll watch for dip-buy opportunities and volume to come in after the presentation.


Biotech Penny Stocks #2: Verastem, Inc. (NASDAQ: VSTM)

VSTM is a developmental stage company working on therapies for cancer patients. There’s no recent news on the company. But it’s holding near its recent highs for a few months.

I’ll watch for a breakout over $3.09 but I’d prefer it had a catalyst and high volume.


Biotech Penny Stocks #3: Mind Medicine (MindMed) Inc. (NASDAQ: MNMD)

MNMD is a biotech company focused on developing psychedelics as a treatment for depression, mental illness, and addiction.

Yesterday, Mind Medicine (MindMed) Inc. uplisted to the Nasdaq. It was previously listed on the OTC markets under the ticker MMEDF.

Before its uplisting, the stock had two huge green days on massive volume. I traded MMEDF on Monday when I dip bought it after it had a morning spike. I bought 7,500 shares at $4.50 and sold at $4.64. I made a profit of $1,050.*

Millionaire Challenge trader Matt Monaco also alerted the stock in the StocksToTrade Small Cap Rockets chat room.* (Again, past performance is not indicative of future results.)

Yesterday it offered a good morning panic dip-buy opportunity. There was a sell-off after it began trading on the Nasdaq as it became a ‘buy the rumor, sell the news’ play. I’ll watch it for another morning panic.


Biotech Penny Stocks #4: Tetra Bio-Pharma Inc. (OTCQB: TBPMF)

TBPMF is another developmental stage biotech company. It was on a tear for five days. But on April 26, it closed off its highs. That was followed by a big gap down and a morning panic dip-buy opportunity.

I’ll watch for another dip-buy opportunity into a big panic.


Biotech Penny Stocks #5: Cerebain Biotech Corp. (OTCPK: CBBT)

CBBT spiked on Monday after it provided an update on its upcoming purchase of PKG, Inc.

StocksToTrade Breaking News Chat alerted the news at 11:24 a.m. Eastern. The stock went from roughly 4 cents a share to just above 8 cents after the news.

The stock’s a former runner so it’s worth watching for more potential upside. But I’ll swing for singles. The chart looks like a #7 from my 7-step framework — the long kiss goodnight.


Biotech Penny Stocks #6: Sesen Bio, Inc. (NASDAQ: SESN)

SESN doesn’t have any recent news since it announced inducements grants to four new employees on April 16. The stock has been uptrending since.

I’ll watch for continued upside but I’d prefer a catalyst to give it the potential to break out over $3.


Biotech Penny Stocks #7: Genocea Biosciences, Inc. (NASDAQ: GNCA)

GNCA is a biotech company that works to develop cancer immunotherapies. The company will provide a 2021 first-quarter corporate update on April 29 at 8:30 am. Eastern.

It’s a former multi-day runner. I’ll watch for a multi-day breakout over $2.90. But again, I’d like to see a catalyst announced to really get it moving.


Biotech Penny Stocks #8: GeneThera, Inc. (OTCPK: GTHR)

On April 27 GTHR announced it hired a consulting firm to help it build laboratory facilities.

“The partnership with Cumming Corporation will allow GeneThera to implement its strategy to build a global network of laboratories designed to prevent control and treat present and future pandemics.”

Read the full press release here.

The stock’s a former spiker. I’ll watch it to gain more momentum to the upside. But I’d like to see even more volume, like when it spiked on April 6.


Biotech Penny Stocks #9: Therapeutic Solutions International, Inc. (OTCPK: TSOI)

On Monday TSOI announced that its immunotherapy shows regression of tumors when combined with low-dose chemotherapy.

I’ll watch this stock for a continued bounce but swing for singles. The chart looks like a  #5 from my 7-step framework. Learn more about it in my “Pennystocking Framework” DVD, or get the DVD as a bonus when you get my 30-Day Bootcamp.


Biotech Penny Stocks #10: Cybin Inc. (OTCQB: CLXPF)

CLXPF is another biotech company developing psychedelics to treat nervous system disorders. It doesn’t have any recent news. It could be running in sympathy to MNMD as a psychedelics play.

On Monday the company announced “it has selected Alcohol Use Disorder (‘AUD’) as the initial target indication for its proprietary deuterated psychedelic tryptamine, CYB003.”

Read the full press release here.

The stock gapped up on April 26 and 27 but couldn’t hold its highs. I’ll watch for panic dip-buying opportunities.


Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

penny stock checklist

I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.


Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…

They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.

If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…

In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.

If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?

What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!


*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. This figure is taken from tracking user accounts on, a trading community platform. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.

Never attempt to copy or mirror the trades discussed on this website or in Small Cap Rockets. Attempting to do so may result in substantial financial losses. Small Cap Rockets alerts are not provided in real-time.  For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained by the instructors.

The post Top Biotech Penny Stocks to Watch — April 28, 2021 appeared first on Timothy Sykes.